SynthesisFrontiers in pharmacology2019

Efficacy and Safety of Bcl-2 Inhibitor Venetoclax in Hematological Malignancy: A Systematic Review and Meta-Analysis of Clinical Trials.

Qingfang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.